Akoya Biosciences IncNASDAQ:AKYA
- LAST PRICE4.7950
- TODAY'S CHANGE (%)0.0750 (1.5890%)
- Bid / Lots4.7400/ 1
- Ask / Lots4.8500/ 1
- Open / Previous Close4.6600 / 4.7200
- Day Range
- 52 Week Range
- Volume216,845
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AKYA |
|---|---|---|
| 09:32 ET | 1050 | 4.4621 |
| 09:37 ET | 18505 | 4.705 |
| 09:39 ET | 1400 | 4.7 |
| 09:42 ET | 300 | 4.765 |
| 09:50 ET | 1007 | 4.87 |
| 09:51 ET | 200 | 4.87 |
| 09:53 ET | 700 | 4.9123 |
| 09:55 ET | 125 | 4.91 |
| 10:02 ET | 300 | 4.8402 |
| 10:04 ET | 2754 | 4.91 |
| 10:11 ET | 1750 | 4.865 |
| 10:27 ET | 100 | 4.845 |
| 10:36 ET | 100 | 4.845 |
| 10:42 ET | 500 | 4.7469 |
| 10:45 ET | 212 | 4.86 |
| 10:47 ET | 848 | 4.865 |
| 10:49 ET | 400 | 4.92 |
| 10:51 ET | 2776 | 4.9124 |
| 10:54 ET | 1104 | 4.915 |
| 10:56 ET | 5751 | 4.98 |
| 10:58 ET | 2300 | 4.9799 |
| 11:02 ET | 357 | 4.98 |
| 11:03 ET | 456 | 4.98 |
| 11:07 ET | 260 | 4.97 |
| 11:09 ET | 100 | 4.955 |
| 11:18 ET | 300 | 4.965 |
| 11:20 ET | 200 | 4.98 |
| 11:21 ET | 4003 | 4.87 |
| 11:23 ET | 100 | 4.87 |
| 11:27 ET | 321 | 4.865 |
| 11:43 ET | 3057 | 4.89 |
| 11:45 ET | 700 | 4.82 |
| 11:54 ET | 300 | 4.84 |
| 11:56 ET | 100 | 4.86 |
| 11:59 ET | 1816 | 4.86 |
| 12:03 ET | 100 | 4.84 |
| 12:06 ET | 100 | 4.86 |
| 12:08 ET | 300 | 4.88 |
| 12:10 ET | 100 | 4.88 |
| 12:12 ET | 100 | 4.845 |
| 12:14 ET | 100 | 4.88 |
| 12:15 ET | 352 | 4.92 |
| 12:17 ET | 100 | 4.94 |
| 12:21 ET | 100 | 4.94 |
| 12:24 ET | 300 | 4.915 |
| 12:28 ET | 100 | 4.95 |
| 12:30 ET | 400 | 4.925 |
| 12:33 ET | 100 | 4.96 |
| 12:35 ET | 100 | 4.97 |
| 12:37 ET | 200 | 4.97 |
| 12:39 ET | 100 | 4.96 |
| 12:44 ET | 100 | 4.915 |
| 12:46 ET | 656 | 4.915 |
| 12:48 ET | 719 | 4.88 |
| 12:50 ET | 400 | 4.93 |
| 01:02 ET | 100 | 4.96 |
| 01:04 ET | 100 | 4.97 |
| 01:06 ET | 1000 | 4.925 |
| 01:09 ET | 100 | 4.97 |
| 01:11 ET | 200 | 4.925 |
| 01:13 ET | 100 | 4.9 |
| 01:18 ET | 200 | 4.915 |
| 01:20 ET | 100 | 4.95 |
| 01:22 ET | 100 | 4.95 |
| 01:31 ET | 100 | 4.95 |
| 01:33 ET | 119759 | 4.6 |
| 01:36 ET | 2860 | 4.75 |
| 01:38 ET | 100 | 4.81 |
| 01:44 ET | 750 | 4.7238 |
| 01:45 ET | 100 | 4.77 |
| 01:47 ET | 400 | 4.765 |
| 01:49 ET | 2100 | 4.8 |
| 01:51 ET | 710 | 4.81 |
| 01:54 ET | 100 | 4.84 |
| 01:56 ET | 100 | 4.84 |
| 01:58 ET | 8492 | 4.76 |
| 02:00 ET | 1200 | 4.71 |
| 02:03 ET | 100 | 4.77 |
| 02:05 ET | 2600 | 4.74 |
| 02:07 ET | 100 | 4.795 |
Nov 13, 2023
DJ Akoya Biosciences Is Maintained at Overweight by Piper Sandler, from 4:19PM ET on Monday Nov 13, 2023 by Dow Jones
4:19PM ET on Monday Nov 13, 2023 by Dow JonesDJ Akoya Biosciences Is Maintained at Overweight by Stephens & Co., from 9:23AM ET on Monday Nov 13, 2023 by Dow Jones
9:23AM ET on Monday Nov 13, 2023 by Dow Jones
Nov 8, 2023
Press Release: Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance, from 4:00PM ET on Wednesday Nov 08, 2023 by Dow Jones
4:00PM ET on Wednesday Nov 08, 2023 by Dow JonesAkoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance, from 4:00PM ET on Wednesday Nov 08, 2023 by Dow Jones
4:00PM ET on Wednesday Nov 08, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Akoya Biosciences Inc | 231.6M | -2.7x | --- |
Butterfly Network Inc | 207.1M | -1.7x | --- |
Edap Tms SA | 188.3M | -8.4x | --- |
Standard BioTools Inc | 206.4M | -2.7x | --- |
Neuropace Inc | 233.9M | -5.4x | --- |
908 Devices Inc. | 249.3M | -6.8x | --- |
Company Information
Akoya Biosciences, Inc. is a life sciences technology company. The Company delivers spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and PhenoImager platforms, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. It provides PhenoImager HT, which is a digital pathology imager featuring rapid whole-slide multispectral scanning of up to seven colors with an 80-slide capacity. It offers a contract research services laboratory, which is called Advanced Biopharma Solutions (ABS).
Contact Information
- Headquarters
- 100 Campus Drive, 6Th FloorMARLBOROUGH, MA, United States 01762
- Phone
- 415-765-6980
- Fax
- ---
Executives
- Chairman of the Board
- Robert Shepler
- President, Chief Executive Officer, Director
- Brian McKelligon
- Chief Financial Officer
- Johnny Ek
- Chief Operating Officer
- Frederic Pla
- General Counsel
- Jennifer Kamocsay
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $231.6M |
|---|---|
Revenue (TTM) | $91.4M |
Shares Outstanding | 49.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.76 |
Book Value | $1.53 |
P/E Ratio | -2.7x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -72.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
